- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
X
XERS
Xeris Biopharma Holdings
6.61
-0.12-1.78%After Hours: 6.72 +0.11 +1.66%19:37 02/20 EST
OPEN/PREV CLOSE6.69/6.73
TODAY RANGE6.51-6.77
VOL2.17M
MARKET CAP1.10B
52 WEEK RANGE3.560-10.08
AVG VOL (3M)2.00M
% TURNOVER1.30%
TURNOVER--
P/E (TTM)-63.9265
% RANGE3.86%
EPS(TTM)-0.1034
P/E(FORWARD)-165.2500
P/B-1,271.1538
BVPS-0.0052
DIVIDEND--
P/S4.864
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.05B
SHARES OUTSTANDING165.92M
NEXT EARNINGS03/04-03/09
FREE FLOAT159.21M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·2d ago
XERS Crosses Below Key Moving Average Level
Simply Wall St·02/04 16:29
How Xeris’ Diversified Product Portfolio and XP-8121 Progress Could Shape Xeris Biopharma (XERS) Investors
Seeking Alpha·02/03 13:52
Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity
TipRanks·01/30 16:10
Analysts’ Top Healthcare Picks: Danaher (DHR), Palvella Therapeutics (PVLA)
NASDAQ·01/29 12:07
Add Up The Parts: IHE Could Be Worth $96
Simply Wall St·01/18 08:18
A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Updated 2025 Revenue Outlook
Simply Wall St·01/16 23:32
Does Xeris Biopharma (XERS) Boosted 2025 Revenue Guidance Strengthen Its Commercial Momentum Narrative?
Simply Wall St·01/10 12:25
Is Xeris Biopharma Holdings (XERS) Price Rally Still Justified After Recent Company Updates
TipRanks·01/09 13:46
Xeris Pharmaceuticals (XERS) Gets a Buy from Jefferies
Dow Jones·01/09 13:37
Xeris Biopharma Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price